Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial
Michèle Tameris, Helen Mearns, Adam Penn‐Nicholson, et al.
The Lancet Respiratory Medicine (2019) Vol. 7, Iss. 9, pp. 757-770
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

100 years of Mycobacterium bovis bacille Calmette-Guérin
Christoph Lange, Peter Aaby, Marcel A. Behr, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 1, pp. e2-e12
Open Access | Times Cited: 146
Next-Generation TB Vaccines: Progress, Challenges, and Prospects
Zhuang Li, Zhaoyang Ye, Linsheng Li, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1304-1304
Open Access | Times Cited: 58
The role of ESAT-6 in tuberculosis immunopathology
Beatriz B. S. Passos, Mariana Araújo‐Pereira, Caian L. Vinhaes, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Tuberculosis vaccines and therapeutic drug: challenges and future directions
Yajing An, Ruizi Ni, Zhuang Li, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 3
Tuberculosis Vaccine Development: Progress in Clinical Evaluation
Suraj B. Sable, James E. Posey, Thomas J. Scriba
Clinical Microbiology Reviews (2019) Vol. 33, Iss. 1
Open Access | Times Cited: 94
New insights into the mycobacterial PE and PPE proteins provide a framework for future research
Louis S. Ates
Molecular Microbiology (2019) Vol. 113, Iss. 1, pp. 4-21
Open Access | Times Cited: 87
Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis
Thomas J. Scriba, Mihai G. Netea, Ann M. Ginsberg
Seminars in Immunology (2020) Vol. 50, pp. 101431-101431
Open Access | Times Cited: 82
New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia
Raquel Tarancón, Jorge Domínguez‐Andrés, Santiago Uranga, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 4, pp. e1008404-e1008404
Open Access | Times Cited: 76
Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology
Stefan H. E. Kaufmann
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 75
Clinical Development of New TB Vaccines: Recent Advances and Next Steps
Mark Hatherill, Richard G. White, Thomas R. Hawn
Frontiers in Microbiology (2020) Vol. 10
Open Access | Times Cited: 73
Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination
Michel Vierboom, Karin Dijkman, Claudia C. Sombroek, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 1, pp. 100185-100185
Open Access | Times Cited: 73
Advances in Diagnosis and Therapy for Bladder Cancer
Xinzi Hu, Guangzhi Li, Song Wu
Cancers (2022) Vol. 14, Iss. 13, pp. 3181-3181
Open Access | Times Cited: 42
The Potential Role of Vaccines in Preventing Antimicrobial Resistance (AMR): An Update and Future Perspectives
Vincenzo Costanzo, Giovanni N. Roviello
Vaccines (2023) Vol. 11, Iss. 2, pp. 333-333
Open Access | Times Cited: 37
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming
Allan C. deCamp, Martin Corcoran, William J. Fulp, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 15
Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled trial
Angelique Kany Kany Luabeya, Virginie Rozot, Claire Imbratta, et al.
The Lancet Global Health (2025)
Open Access | Times Cited: 1
Chronic Immune Activation in TB/HIV Co-infection
Riti Sharan, Allison N. Bucşan, Shashank Ganatra, et al.
Trends in Microbiology (2020) Vol. 28, Iss. 8, pp. 619-632
Open Access | Times Cited: 54
Update on TB Vaccine Pipeline
Carlos Martı́n, Nacho Aguiló, Dessislava Marinova, et al.
Applied Sciences (2020) Vol. 10, Iss. 7, pp. 2632-2632
Open Access | Times Cited: 52
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG
Carlos Martı́n, Dessislava Marinova, Nacho Aguiló, et al.
Vaccine (2021) Vol. 39, Iss. 50, pp. 7277-7285
Open Access | Times Cited: 48
BCG‐induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next‐generation vaccines
Mitchell Foster, Philip C. Hill, Todia P. Setiabudiawan, et al.
Immunological Reviews (2021) Vol. 301, Iss. 1, pp. 122-144
Open Access | Times Cited: 43
Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection
Karin Dijkman, Nacho Aguiló, Charelle Boot, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 1, pp. 100187-100187
Open Access | Times Cited: 42
It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity
Sasha E. Larsen, Brittany D. Williams, Maham Rais, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates
Fangbin Zhou, Dongmei Zhang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro–American genetic background confers optimal vaccine potential
I Pérez, Santiago Uranga, Fadel Sayes, et al.
EBioMedicine (2020) Vol. 55, pp. 102761-102761
Open Access | Times Cited: 43
MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies
Andrew White, Laura Sibley, Charlotte Sarfas, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 39
Controlled Human Infection Models To Accelerate Vaccine Development
Robert K. M. Choy, A. Louis Bourgeois, Christian F. Ockenhouse, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top